Intellectual Property

  • November 26, 2004

    Wilmer Cutler Eyes China IP With New Beijing Outpost

    Wilmer Cutler Pickering Hale and Dorr has opened its first new office since the merger between Wilmer Cutler and Hale and Dorr, eyeing growing opportunities in intellectual property on mainland China with a new outpost in Beijing.

  • November 29, 2004

    Canada's Generics Export Program Falters Amid Litigation Fears

    Canadian generic drug makers are opting out of the country’s trailblazing efforts to supply developing countries with patented drugs, blaming excessive safeguards for patent holders under the new law, according to a published report.

  • November 26, 2004

    Pfizer Sues Chinese Agency Over Rejected Envacar Trademark

    Pfizer Inc. has sued China's State Administration for Industry and Commerce, alleging that the agency unfairly rejected its application for domestic trademark protection for blood-pressure drug Envacar.

  • November 26, 2004

    PCTEL, 3Com Settle Modem Patent Dispute

    High-tech rivals PCTEL and 3COM, which have been trading complaints in federal court in Northern California in a dispute over patented modem technology, have settled their lawsuits with a cross-licensing agreement, the two companies said.

  • November 22, 2004

    USPTO Fees To Increase, But Funding Diversion Could Continue

    In a setback for lobbyists who have fought the diversion of fees from the U.S. Patent and Trademark Office, U.S. lawmakers have voted to raise the fees charged by the USPTO but will still allow those funds to be spent elsewhere.

  • November 22, 2004

    U.S. To Create IP Czar To Oversee Federal Programs

    U.S. lawmakers have passed a funding bill that would create an "intellectual property czar" whose agency would oversee all IP-related government programs in the U.S. and abroad.

  • November 26, 2004

    E.U. Delays Vote On Software Patents Again

    European Union governments have once again delayed voting on a proposal for a controversial law that opponents say would allow the patenting of software in Europe.

  • November 22, 2004

    Townsend Settles Suit Brought By Disgruntled Biotech Client

    Townsend and Townsend and Crew has quietly settled a lawsuit that accused the California intellectual-property law firm of legal malpractice, breach of fiduciary duty and breach of contract over a decade of service.

  • December 1, 2004

    Morrison & Foerster Sees Growth Potential In New IP Venture Group

    Morrison & Foerster’s upstart IP venture group is expected to help generate significant new work for the general-practice firm, according to the group’s founders.

  • November 26, 2004

    U.S. Bill Would Protect Research Collaborations From Patent Challenges

    The U.S. Congress has passed a bill designed to shield private companies that collaborate with universities from legal challenges to their patents, a move that is likely to bolster biotech companies in particular.

  • November 29, 2004

    WIPO Snubs U.S. Bid To Extend Broadcasting Treaty To Webcasts

    The World Intellectual Property Organization (WIPO) has rejected a proposal by the U.S. to extend copyright protection for television and radio productions to cover webcasting on the internet in a revised broadcast treaty.

  • November 30, 2004

    Pfizer Withheld Crucial Data In Lipitor Patent Filing, Ranbaxy Claims

    Pfizer Inc. withheld crucial scientific data that might have influenced the patent review board's decision to grant the drug maker a second patent for Lipitor, attorneys for Indian generics maker Ranbaxy Laboratories Ltd. argued at the opening of the closely watched trial over patent rights to the blockbuster anti-cholesterol drug.

  • November 22, 2004

    Teamsters Sue AstraZeneca Over Nexium Claims

    Only a month after it was slapped with a similar lawsuit by the largest union in the U.S., several New York Teamsters unions have filed a separate class-action lawsuit against Swedish-U.K. drug maker AstraZenca over the way it handled the patent expiration on blockbuster heartburn drug Prilosec.

  • November 22, 2004

    Jury Rules For Inverness In Patent Suit Vs. Acon Labs

    In a move likely to lead to a preliminary injunction order, a federal jury has found that three claims central to medical device maker Inverness Medical Innovations’ lawsuit against rival Acon Laboratories are valid.

  • November 19, 2004

    U.S., E.U. And Japan To Step Up Patent Harmonization

    Heads of the world’s top three patent offices have agreed to speed up efforts to harmonize key features.

  • November 19, 2004

    Sutherland Hires IP Litigators From Pillsbury Winthrop

    General-practice firm Sutherland Asbill & Brennan has snatched a group of intellectual property litigators from the Northern Virginia office of Pillsbury Winthrop.

  • November 19, 2004

    VC Firm Targets Patents, Raises $350M: Report

    A venture capital firm headed by former Microsoft executives is buying patents that could pose legal threats to its powerful high-tech investors, according to a published report.

  • November 19, 2004

    Sterne Kessler Sees Nanotech As Next IP Frontier

    Two decades after Sterne, Kessler, Goldstein & Fox helped pioneer the biotech intellectual property practice, the Washington, D.C.-based specialist firm has set its sights on nanotechnology as one of the most promising fields of the future.

  • November 18, 2004

    ITC Clears Carsem In Chip Packaging Dispute With Amkor

    In a preliminary decision, the U.S. International Trade Commission has cleared semiconductor packaging company Carsem of infringing patents held by rival Amkor Technology, Inc.

  • November 19, 2004

    Morrison & Foerster Unveils IP Venture Group

    General-practice firm Morrison & Foerster has launched a new group that will help evaluate the intellectual property of upstart life-sciences companies for venture capitalists.